insights_auto
Why is BMY down 2,57%?
Dive Deeperchevron_right
BMY:NYSE
Bristol-Myers Squibb Co
57,60 $
arrow_downward
-2,57%(-1,52) 1D
12 қаз., 15:51:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BMY...
Open
60,11 $
High
60,68 $
Low
56,72 $
Mkt. cap
117,66 млрд
Avg. vol.
11,39 млн
Volume
16,15 млн
Dividend
4,38%
Quarterly dividend
0,63 $
Ex-dividend date
2026 ж. 02 қаз.
P/E ratio
12,69
52-wk high
68,64 $
52-wk low
42,52 $
EPS
4,54 $
Beta
0,19
Shares outstanding
2,04 млрд
No. of employees
32 мың
Open
60,11 $
High
60,68 $
Low
56,72 $
Mkt. cap
117,66 млрд
Avg. vol.
11,39 млн
Volume
16,15 млн
Dividend
4,38%
Quarterly dividend
0,63 $
Ex-dividend date
2026 ж. 02 қаз.
P/E ratio
12,69
52-wk high
68,64 $
52-wk low
42,52 $
EPS
4,54 $
Beta
0,19
Shares outstanding
2,04 млрд
No. of employees
32 мың
News stories
From web sources and news partners
GuruFocus
·
55 минут бұрын
Bristol Myers (BMY) Reports Promising Phase 3 Trial Results for Admilparant in IPF
News Corp
·
1 сағат бұрын
Bristol Myers Stock Tumbles on ‘Confounding’ Trial Results
Barron's
·
2 сағат бұрын
Bristol Myers Stock Tumbles on ‘Confounding’ Trial Results
The Globe and Mail
·
2 сағат бұрын
BMY Surges 35.7% in a Year: Should You Buy, Sell or Hold the Stock?
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Co
CEOChris Boerner
Employees32,5 мың
Founded1887
HeadquartersНью-Йорк, Нью-Йорк, Америка Құрама Штаттары
SectorPharmaceutical industry
Websitebms.com